Obesity is estimated to affect 300 million people worldwide. Furthermore, abdominal adiposity—measured by waist circumference—is independently associated with mortality. This association remains ...
Growth hormone, produced by the pituitary gland, plays a critical role in cell regeneration, growth, and maintaining healthy body tissue, including the brain and vital organs. While synthetic human ...
The diagnosis of growth hormone deficiency in adults is always challenging, but it is particularly difficult in the case of obese adults. As obesity is known to independently decrease growth hormone ...
Medical Oncologists' Attitudes and Practice in Cancer Pain Management: A National Survey Between 1997 and 2008, 192 pediatric patients with localized primary brain tumors (ependymoma, n = 88; ...
More than 2.5 million people in the United States alone experience a traumatic brain injury, or TBI, each year. Some of these people are plagued by a seemingly unrelated cascade of health issues for ...
The European Medicines Agency (EMA) has given the 'green light' to lonapegsomatropin (TransCon hGH, Ascendis Pharma), a long-acting, once-weekly formulation of human growth hormone, for growth failure ...
Lonapegsomatropin statistically significantly reduced trunk percent fat at week 38 compared with placebo (-1.7% vs 0.4%, respectively) in adult GHD patients. The Food and Drug Administration (FDA) has ...
The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...
Between 1997 and 2008, 192 pediatric patients with localized primary brain tumors (ependymoma, n = 88; low-grade glioma, n = 51; craniopharyngioma, n = 28; high-grade glioma, n = 23; and other tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results